Eli Lilly’s Chief Scientific Officer, Dan Skovronsky, is pushing the boundaries of obesity treatment. With Zepbound already on the market, Lilly is developing a daily pill and a potentially more powerful shot. The company has nine obesity drugs in clinical trials. Skovronsky emphasizes that future drugs must offer more than just weight loss. Amgen’s MariTide, for example, helped patients lose up to 20% of their body weight in a Phase 2 study, but its stock fell 5% due to competition concerns. Lilly is exploring incretin medicines for treating conditions like sleep apnea, addiction, heart disease, inflammation, and gastrointestinal issues. Skovronsky envisions pills like orforglipron reaching global markets and sees potential in drugs like retatrutide for even greater weight loss.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
